-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
المؤلفون: Li J; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lan Z; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liao W; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China., Horner JW; TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xu X; TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liu J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yoshihama Y; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jiang S; TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shim HS; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Slotnik M; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., LaBella KA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu CJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dunner K Jr; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hsu WH; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee R; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khanduri I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Terranova C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Akdemir K; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chakravarti D; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shang X; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Spring DJ; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang YA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Indiana University, Indianapolis, IN, USA., DePinho RA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. RDePinho@mdanderson.org.
المصدر: Nature [Nature] 2023 Jul; Vol. 619 (7970), pp. 632-639. Date of Electronic Publication: 2023 Jun 21.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
مواضيع طبية MeSH: Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/metabolism , Colorectal Neoplasms*/pathology , Histone Demethylases*/genetics , Histone Demethylases*/metabolism , Minor Histocompatibility Antigens*/genetics , Minor Histocompatibility Antigens*/metabolism , Sex Characteristics*, Animals ; Female ; Humans ; Male ; Mice ; CD8-Positive T-Lymphocytes/immunology ; Disease Models, Animal ; Mice, Transgenic ; Up-Regulation
-
7دورية أكاديمية
المؤلفون: Mokkapati S; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Narayan VM; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Manyam GC; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Lim AH; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Duplisea JJ; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Kokorovic A; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Miest TS; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Mitra AP; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Plote D; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Anand SS; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Metcalfe MJ; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Dunner K Jr; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Johnson BA; James Buchanan Brady Urological Institute, John Hopkins Greenberg Bladder Cancer Institute, John Hopkins University, School of Medicine, Baltimore, MD, USA., Czerniak BA; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Nieminen T; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Heikura T; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., Yla-Herttuala S; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Parker NR; Middlesex, Hamesman, Ltd., Edgware, London, UK., Schluns KS; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA., McConkey DJ; James Buchanan Brady Urological Institute, John Hopkins Greenberg Bladder Cancer Institute, John Hopkins University, School of Medicine, Baltimore, MD, USA., Dinney CP; University of Texas MD Anderson Cancer Center, Smith Research Building, 7777 Knight Road, Houston, TX 77584, USA.
المصدر: Molecular therapy oncolytics [Mol Ther Oncolytics] 2022 Jun 10; Vol. 26, pp. 141-157. Date of Electronic Publication: 2022 Jun 10 (Print Publication: 2022).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101666776 Publication Model: eCollection Cited Medium: Print ISSN: 2372-7705 (Print) Linking ISSN: 23727705 NLM ISO Abbreviation: Mol Ther Oncolytics Subsets: PubMed not MEDLINE
-
8
المؤلفون: Zhang Q; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Riley-Gillis B; AbbVie Inc., North Chicago, IL, USA., Han L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jia Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Lodi A; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Zhang H; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Ganesan S; Université de Paris, Institut de la Recherche Saint-Louis (IRSL), Inserm Unit 1131, Paris, France., Pan R; Dana-Farber Cancer Institute, Boston, MA, USA., Konoplev SN; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sweeney SR; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Ryan JA; Dana-Farber Cancer Institute, Boston, MA, USA., Jitkova Y; Princess Margaret Cancer Center, Toronto, ON, Canada., Dunner K Jr; High Resolution Electron Microscopy Facility, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Grosskurth SE; AbbVie Inc., North Chicago, IL, USA., Vijay P; AbbVie Inc., North Chicago, IL, USA., Ghosh S; AbbVie Inc., North Chicago, IL, USA., Lu C; AbbVie Inc., North Chicago, IL, USA., Ma W; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kurtz S; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Ruvolo VR; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weng CC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ramage CL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Baran N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shi C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Hematology, The First Hospital Affiliated Harbin Medical University, Harbin, China., Cai T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davis RE; Department of Lymphoma & Myeloma Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Battula VL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mi Y; Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Wang J; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tyner JW; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Schimmer A; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Letai A; Dana-Farber Cancer Institute, Boston, MA, USA., Padua RA; Université de Paris, Institut de la Recherche Saint-Louis (IRSL), Inserm Unit 1131, Paris, France., Bueso-Ramos CE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tiziani S; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Leverson J; AbbVie Inc., North Chicago, IL, USA., Popovic R; AbbVie Inc., North Chicago, IL, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mkonople@mdanderson.org.
المصدر: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2022 Apr 01; Vol. 7 (1), pp. 110. Date of Electronic Publication: 2022 Apr 01.
نوع المنشور: Published Erratum
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: PubMed not MEDLINE; MEDLINE
-
9دورية أكاديمية
المؤلفون: Zhang Q; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Riley-Gillis B; AbbVie Inc., North Chicago, IL, USA., Han L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jia Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Lodi A; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Zhang H; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Ganesan S; Université de Paris, Institut de la Recherche Saint-Louis (IRSL), Inserm Unit 1131, Paris, France., Pan R; Dana-Farber Cancer Institute, Boston, MA, USA., Konoplev SN; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sweeney SR; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Ryan JA; Dana-Farber Cancer Institute, Boston, MA, USA., Jitkova Y; Princess Margaret Cancer Center, Toronto, ON, Canada., Dunner K Jr; High Resolution Electron Microscopy Facility, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Grosskurth SE; AbbVie Inc., North Chicago, IL, USA., Vijay P; AbbVie Inc., North Chicago, IL, USA., Ghosh S; AbbVie Inc., North Chicago, IL, USA., Lu C; AbbVie Inc., North Chicago, IL, USA., Ma W; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kurtz S; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Ruvolo VR; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weng CC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ramage CL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Baran N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shi C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Hematology, The First Hospital Affiliated Harbin Medical University, Harbin, China., Cai T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davis RE; Department of Lymphoma & Myeloma Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Battula VL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mi Y; Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Wang J; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tyner JW; Department of Cell, Developmental & Cancer Biology, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Schimmer A; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Letai A; Dana-Farber Cancer Institute, Boston, MA, USA., Padua RA; Université de Paris, Institut de la Recherche Saint-Louis (IRSL), Inserm Unit 1131, Paris, France., Bueso-Ramos CE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tiziani S; Department of Nutritional Sciences, Department of Pediatrics, Department of Oncology, Dell Medical School, The University of Texas at Austin, Austin, TX, 78712, USA., Leverson J; AbbVie Inc., North Chicago, IL, USA., Popovic R; AbbVie Inc., North Chicago, IL, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mkonople@mdanderson.org.
المصدر: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2022 Feb 21; Vol. 7 (1), pp. 51. Date of Electronic Publication: 2022 Feb 21.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE
مواضيع طبية MeSH: Bridged Bicyclo Compounds, Heterocyclic*/pharmacology , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/metabolism , MAP Kinase Signaling System*/drug effects , Myeloid Cell Leukemia Sequence 1 Protein*/genetics , Myeloid Cell Leukemia Sequence 1 Protein*/metabolism , Proto-Oncogene Proteins c-bcl-2*/antagonists & inhibitors , Proto-Oncogene Proteins c-bcl-2*/genetics , Proto-Oncogene Proteins c-bcl-2*/metabolism , Sulfonamides*/pharmacology , ras Proteins*, Cell Line, Tumor ; Drug Resistance, Neoplasm ; Humans
-
10دورية أكاديمية
المؤلفون: Verrico CD; Department of Psychiatry.; Department of Pharmacology, Baylor College of Medicine, Houston, TX, United States., Wesson S; Sunset Animal Hospital, Houston, TX, United States., Konduri V; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States., Hofferek CJ; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States., Vazquez-Perez J; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States., Blair E; Valimenta Labs, Fort Collins, CO, United States., Dunner K Jr; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, United States., Salimpour P; Boston University School of Medicine, Boston, MA, United States., Decker WK; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.; Center for Cell and Gene Therapy.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States., Halpert MM; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, United States.
المصدر: Pain [Pain] 2020 Sep 01; Vol. 161 (9), pp. 2191-2202.
نوع المنشور: Journal Article; Randomized Controlled Trial, Veterinary; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7508686 Publication Model: Print Cited Medium: Internet ISSN: 1872-6623 (Electronic) Linking ISSN: 03043959 NLM ISO Abbreviation: Pain Subsets: MEDLINE
مواضيع طبية MeSH: Arthralgia*/drug therapy , Arthralgia*/veterinary , Cannabidiol*/therapeutic use , Osteoarthritis*/complications , Osteoarthritis*/drug therapy , Osteoarthritis*/veterinary , Dog Diseases*/drug therapy, Animals ; Dogs ; Mice ; Cannabis ; Double-Blind Method ; Disease Models, Animal